Fair Value Measurements (Tables)

9 Months Ended

Mar. 31, 2015

Fair Value Disclosures [Abstract]

Schedule Of Fair Value Hierarchy, Assets (Liabilities) Carried At Fair Value

(in thousands)	Level 1		Level 2			Level 3			Total
Contingent consideration	$	—	$	—		$	(9,218	)	$	(9,218	)
Interest rate derivative instruments	—		530			—			530
Foreign currency exchange contracts	—		(20,039		)	—			(20,039		)
Total	$	—	$	(19,509	)	$	(9,218	)	$	(28,727	)

(in thousands)	Level 1		Level 2		Level 3			Total
Contingent consideration	$	—	$	—	$	(5,152	)	$	(5,152	)
Interest rate derivative instruments	—		580		—			580
Foreign currency exchange contracts	—		6,463		—			6,463
Total	$	—	$	7,043	$	(5,152	)	$	1,891

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]

The recurring Level 3 fair value measurements of our contingent consideration liability include the following significant unobservable inputs:

	ClinIntel
Unobservable Input	Range
Discount rate	4%
Probability of achieving financial targets	12.5% to 75%
Projected period of payment	August 2016

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table provides a summary of the change in our valuation of the fair value of the contingent consideration, which was determined by Level 3 inputs:

(in thousands)	Fair Value
Balance at June 30, 2014	$	5,152
Additions of contingent consideration due to acquisitions	9,882
Change in fair value of contingent consideration	(4,964		)
Effect of changes in exchange rates used for translation	(852		)
Balance at March 31, 2015	$	9,218